Gilead Sciences

Prevention Specialist - HIV Prevention, Downtown Manhattan

United States

Not SpecifiedCompensation
Entry Level & New GradExperience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

Candidates should possess a Bachelor’s degree and demonstrate at least 3 years of experience in healthcare sales, preferably within HIV or infectious disease. Strong presentation and communication skills are essential, along with the ability to distill complex clinical concepts into easily understandable messages for diverse audiences. A proven track record of effectively interacting with healthcare professionals is required.

Responsibilities

As a Prevention Specialist, you will represent Gilead’s products and services to a defined customer base, focusing on generating and growing sales within the Downtown Manhattan territory by consistently achieving or exceeding sales targets. You will establish strong relationships with healthcare providers through in-person representation, face-to-face meetings, and strategic partnerships, delivering timely disease awareness information and clinical updates. Additionally, you will collaborate with local cross-functional colleagues, partner with healthcare organizations, and demonstrate adherence to Gilead’s compliance standards and ethical behavior.

Skills

Healthcare engagement
Disease awareness
Clinical updates
Account management
Relationship building
Sales strategy

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Key Metrics

Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Paid family time off and paid parental time off
Generous 401(k) contribution matching
Comprehensive medical plans that cover both physical and mental healthcare
Global Wellbeing Reimbursement
Time Off
Global Volunteer Day
Giving Together Program
Employee Support Programs
Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.
Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.
Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.
Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.
Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.
Investment in digital health technologies enhances Gilead's R&D and patient engagement.
Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI